Suppr超能文献

一种在诊断血液病理学中常规使用BIOMED-2聚合酶链反应(PCR)检测法检测B细胞和T细胞克隆性的实用策略。

A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B- and T-cell clonality in diagnostic haematopathology.

作者信息

Liu Hongxiang, Bench Anthony J, Bacon Chris M, Payne Karen, Huang Yuanxue, Scott Mike A, Erber Wendy N, Grant John W, Du Ming-Qing

机构信息

Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK.

出版信息

Br J Haematol. 2007 Jul;138(1):31-43. doi: 10.1111/j.1365-2141.2007.06618.x.

Abstract

BIOMED-2 polymerase chain reaction (PCR) assays for clonality analysis of immunoglobulin (IG) and T-cell receptor (TCR) gene rearrangements were evaluated in routine haematopathological practice where paraffin-embedded tissues constitute the majority of specimens. One hundred and twenty-five fresh/frozen and 316 paraffin specimens were analysed for DNA quality and clonality. Seventy-nine per cent of paraffin specimens yielded PCR products of over 300 bp. These specimens and all fresh/frozen specimens were analysed with the complete set of BIOMED-2 reactions for IG (8 reactions) and/or TCR (6 reactions) gene rearrangements. The rate of detection of clonality was 96% in mature B-cell neoplasms and 98% in mature T-cell neoplasms and there were no significant differences in these rates between paraffin and fresh/frozen specimens. As the value of sole use of any individual BIOMED-2 reaction in clonality detection was limited, we assessed combinations of reactions that gave the greatest sensitivity with fewest reactions and were applicable for both fresh/frozen and paraffin specimens. For IG gene rearrangements, three reactions combining one targeting the IG heavy chain framework-2 region and two targeting the IG kappa locus achieved a 91% detection rate. For TCR gene rearrangements, the two TCR gamma reactions gave a 94% detection rate. We therefore recommend this strategy as the first-line assays for routine B- and T-cell clonality analysis in diagnostic haematopathology.

摘要

在以石蜡包埋组织为主要标本来源的常规血液病理学实践中,对用于免疫球蛋白(IG)和T细胞受体(TCR)基因重排克隆性分析的BIOMED-2聚合酶链反应(PCR)检测方法进行了评估。对125份新鲜/冷冻标本和316份石蜡标本进行了DNA质量和克隆性分析。79%的石蜡标本产生了超过300 bp的PCR产物。使用针对IG(8种反应)和/或TCR(6种反应)基因重排的全套BIOMED-2反应对这些标本以及所有新鲜/冷冻标本进行了分析。成熟B细胞肿瘤的克隆性检出率为96%,成熟T细胞肿瘤的克隆性检出率为98%,石蜡标本和新鲜/冷冻标本在这些检出率上没有显著差异。由于在克隆性检测中单独使用任何一种BIOMED-2反应的价值有限,我们评估了能以最少反应获得最大灵敏度且适用于新鲜/冷冻标本和石蜡标本的反应组合。对于IG基因重排,一种针对IG重链框架2区和两种针对IGκ基因座的反应组合的检出率达到了91%。对于TCR基因重排,两种TCRγ反应的检出率为94%。因此,我们推荐这种策略作为诊断血液病理学中常规B细胞和T细胞克隆性分析的一线检测方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验